892
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Archaea influence composition of endoscopically visible ileocolonic biofilms

, , , , , , , , , , , , & show all
Article: 2359500 | Received 06 Oct 2023, Accepted 21 May 2024, Published online: 02 Jun 2024

References

  • Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol [Internet]. 2020;5(10):908–14. doi:10.1016/S2468-1253(20)30217-X.
  • Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol [Internet]. 2012;10(7):712–721. doi:10.1016/j.cgh.2012.02.029.
  • Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EMM, Rajilić-Stojanović M, Schemann M. et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016;2(1):16014. doi:10.1038/nrdp.2016.14.
  • Kaplan GG. The global burden of IBD: From 2015 to 2025. Nat Rev Gastroenterol Hepatol [Internet]. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150.
  • Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. et al. Ulcerative colitis. Nat Rev Dis Primers [Internet]. 2020;6(1). doi:10.1038/s41572-020-0205-x.
  • Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn’s disease. Nat Rev Dis Primers [Internet]. 2020;6(1). doi:10.1038/s41572-020-0156-2.
  • Dammann K, Khare V, Gasche C. Tracing PAKs from GI inflammation to cancer. Gut. 2014;63(7):1173–1184. doi:10.1136/gutjnl-2014-306768.
  • Frick A, Khare V, Paul G, Lang M, Ferk F, Knasmüller S, Beer A, Oberhuber, G Gasche, C. Overt increase of oxidative stress and DNA damage in murine and human colitis and colitis-associated neoplasia. Mol Cancer Res. 2018;16(4):634–642. doi:10.1158/1541-7786.MCR-17-0451.
  • Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology [Internet]. 2022;162(3):715–730.e3. doi:10.1053/j.gastro.2021.10.035.
  • Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology [Internet]. 2011;140(6):1807–1816.e1. doi:10.1053/j.gastro.2011.01.057.
  • Frick A, Khare V, Jimenez K, Dammann K, Lang M, Krnjic A, Gmainer C, Baumgartner M, Mesteri I, Gasche C. A novel PAK1–Notch1 axis regulates crypt homeostasis in intestinal inflammation. Cmgh [Internet]. 2021;11(3):892–907.e1. doi:10.1016/j.jcmgh.2020.11.001.
  • Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–1801. doi:10.1053/j.gastro.2011.07.043.
  • Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9.
  • Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF. et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):1–12. doi:10.1126/scitranslmed.aap8914.
  • Pittayanon R, Lau JT, Leontiadis GI, Tse F, Yuan Y, Surette M, Moayyedi P. Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review. Gastroenterology [Internet]. 2020;158(4):930–946.e1. doi:10.1053/j.gastro.2019.11.294.
  • Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Gut microbiota in patients with irritable bowel syndrome—a systematic review. Gastroenterology [Internet]. 2019;157(1):97–108. doi:10.1053/j.gastro.2019.03.049.
  • Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology [Internet]. 2015;149(1):102–109.e6. doi:10.1053/j.gastro.2015.04.001.
  • Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17–24. doi:10.1016/S2468-1253(17)30338-2.
  • Borrel G, Brugère JF, Gribaldo S, Schmitz RA, Moissl-Eichinger C. The host-associated archaeome. Nat Rev Microbiol. 2020;18(11):622–636. doi:10.1038/s41579-020-0407-y.
  • Hoegenauer C, Hammer HF, Mahnert A, Moissl-Eichinger C. Methanogenic archaea in the human gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2022;19(12):805–813. doi:10.1038/s41575-022-00673-z.
  • Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, de Weerd HH, Boekhout T, Fornai M, Masclee AA. et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology [Internet]. 2017;153(4):1026–1039. doi:10.1053/j.gastro.2017.06.004.
  • Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable bowel syndrome, particularly the constipation-predominant form, involves an increase in Methanobrevibacter smithii, which is associated with higher methane production. Gut Liver. 2016;10(6):932–938. doi:10.5009/gnl15588.
  • Lecours PB, Marsolais D, Cormier Y, Berberi M, Haché C, Bourdages R, Duchaine C. Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One. 2014;9(2):e87734. doi:10.1371/journal.pone.0087734.
  • Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I. et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039–1048. doi:10.1136/gutjnl-2015-310746.
  • Jalanka-Tuovinen J, Salojärvi J, Salonen A, Immonen O, Garsed K, Kelly FM, Zaitoun A, Palva A, Spiller RC, de Vos WM. et al. Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2014;63(11):1737–1745. doi:10.1136/gutjnl-2013-305994.
  • Koskinen K, Pausan MR, Perras A, Beck M, Bang C, Mora M, Schilhabel A, Schmitz R, Moissl-Eichinger C. et al. First insights into the diverse human archaeome: specific detection of archaea in the gastrointestinal tract, lung, and nose and on skin. MBio. 2017;8(6):e00824–17. doi:10.1128/mBio.00824-17.
  • Friedman ES, Bittinger K, Esipova TV, Hou L, Chau L, Jiang J, Mesaros C, Lund PJ, Liang X, FitzGerald GA. et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A. 2018;115(16):4170–4175. doi:10.1073/pnas.1718635115.
  • Sundin OH, Mendoza-Ladd A, Zeng M, Diaz-Arévalo D, Morales E, Fagan BM, Ordoñez J, Velez P, Antony N, McCallum RW. et al. The human jejunum has an endogenous microbiota that differs from those in the oral cavity and colon. BMC Microbiol. 2017;17(1):1–17. doi:10.1186/s12866-017-1059-6.
  • Tropini C, Earle KA, Huang KC, Sonnenburg JL. The gut microbiome: connecting spatial organization to Function. Cell Host Microbe [Internet]. 2017;21(4):433–442. doi:10.1016/j.chom.2017.03.010.
  • Lee J-Y, Tsolis RM, Bäumler AJ. The microbiome and gut homeostasis. Science (80-) [Internet]. 2022;377(6601). doi:10.1126/science.abp9960.
  • Baumgartner M, Lang M, Holley H, Crepaz D, Hausmann B, Pjevac P, Moser D, Haller F, Hof F, Beer A. et al. Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis. Gastroenterology [Internet]. 2021; 1–12. doi:10.1053/j.gastro.2021.06.024.
  • Toole GO, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54(1):49–79. doi:10.1146/annurev.micro.54.1.49.
  • Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. doi:10.1038/nrmicro821.
  • Watnick P, Kolter KR. Biofilm, city of microbes. J Bacteriol. 2000;182(10):2675–2679. doi:10.1128/JB.182.10.2675-2679.2000.
  • Wong B, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012;10(9):1009–15e3. doi:10.1016/j.cgh.2012.05.006.
  • Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EH. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol [Internet]. 2021;17(11):1–27. doi:10.1371/journal.pcbi.1009442.
  • Drewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, Roslani AC, Wick EC, Mongodin EF, Loke MF. et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. npj Biofilms Microbiomes [Internet]. 2017;3(1). doi:10.1038/s41522-017-0040-3.
  • Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A. 2014;111(51):18321–18326. doi:10.1073/pnas.1406199111.
  • Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science (80-). 2018;359(6375):592–597. doi:10.1126/science.aah3648.
  • Motta JP, Wallace JL, Buret AG, Deraison C, Vergnolle N. Gastrointestinal biofilms in health and disease. Nat Rev Gastroenterol Hepatol [Internet]. 2021;18(5):314–334. doi:10.1038/s41575-020-00397-y.
  • Mar Rodríguez M, Pérez D, Javier Chaves F, Esteve E, Marin-Garcia P, Xifra G, Vendrell J, Jové M, Pamplona R, Ricart W. et al. Obesity changes the human gut mycobiome. Sci Rep. 2015;5(1):1–15. doi:10.1038/srep14600.
  • Lee JY, Cevallos SA, Byndloss MX, Tiffany CR, Olsan EE, Butler BP, Young BM, Rogers AWL, Nguyen H, Kim K. et al. High-fat diet and antibiotics cooperatively impair mitochondrial bioenergetics to trigger dysbiosis that exacerbates pre-inflammatory bowel disease. Cell Host Microbe. 2020;28(2):273–284.e6. doi:10.1016/j.chom.2020.06.001.
  • Gulhane M, Murray L, Lourie R, Tong H, Sheng YH, Wang R, Kang A, Schreiber V, Wong KY, Magor G. et al. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci Rep [Internet]. 2016;6(1):1–17. doi:10.1038/srep28990.
  • Crost EH, Tailford LE, Monestier M, Swarbreck D, Henrissat B, Crossman LC, Juge N. The mucin-degradation strategy of Ruminococcus gnavus: The importance of intramolecular trans-sialidases. Gut Microbes [Internet]. 2016;7(4):302–312. doi:10.1080/19490976.2016.1186334.
  • Chand D, Avinash VS, Yadav Y, Pundle AV, Suresh CG, Ramasamy S. Molecular features of bile salt hydrolases and relevance in human health. Biochim Biophys Acta – Gen Subj [Internet]. 2017;1861(1):2981–2991. doi:10.1016/j.bbagen.2016.09.024.
  • Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RMF, Wexler HM. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb Pathog. 2007;43(2):78–87. doi:10.1016/j.micpath.2007.04.002.
  • Madigan KE, Richa Bundy RBW. Distinctive clinical correlates of small intestinal bacterial overgrowth with methanogens. Clin Gastroenterol Hepatol. 2021;20(7):1598–1605. doi:10.1016/j.cgh.2021.09.035.
  • Gandhi A, Shah A, Jones MP, Koloski N, Talley NJ, Morrison M, Holtmann G. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis. Gut Microbes [Internet]. 2021;13(1):1–16. doi:10.1080/19490976.2021.1933313.